Market research
PHF.F Pharmagest Interactive SA
F EUR Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 502M
- P/E ratio
- 20.88
- Analyst target
- Not available
- Dividend yield
- 4.2%
- Beta
- 0.56
Profile
Company facts
- Exchange
- F
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Health Information Services
- ISIN
- FR0012882389
- Market cap
- 502M
- P/E ratio
- 20.88
- Analyst target
- Not available
- Dividend yield
- 4.2%
- Beta
- 0.56
About
About Pharmagest Interactive SA
Equasens Société anonyme provides healthcare IT solutions in France, Italy, Belgium, Germany, the United Kingdom, and internationally. The company operates through Sales of Configurations and Hardware, Maintenance Services and Subscriptions, and Software and Services segments. The company engages in publishing and distribution of pharmacy, practice, management software and related offerings for pharmacies, medical-social establishments, doctors, and medical auxiliaries; distribution of computer equipment, turnkey installation and training; after-sales services, and telephone support and maintenance; and data backup, intermediation, and vocational training services. It also provides medical remote monitoring systems, develops a structured medical speech recognition solution, and designs and manufactures connected electronic devices and equipment, as well as offers interoperability solutions. In addition, the company offers financing platform to facilitate multi-donor management, and financing solutions for leased assets for healthcare professionals and others. It serves healthcare facilities and healthcare professionals. The company was incorporated in 1996 and is headquartered in Villers-lès-Nancy, France. Equasens Société anonyme operates as a subsidiary of Marque Verte Sante.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the PHF.F discussion.
5 years, 4 months ago
Pharmagest Interactive SA is currently in a long term downtrend where the price is trading 4.3% below its 200 day moving average.
From a valuation standpoint, the stock is 99.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 5.1.
Finally, its free cash flow fell by 13.1% to $3M since the same quarter in the previous year.
Based on the above factors, Pharmagest Interactive SA gets an overall score of 1/5.